Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA minor UI text update for the contact information link and a new revision badge (v3.7.0) replacing the previous badge (v3.6.6) appear in the study record history, indicating a small interface change and a platform version update.SummaryDifference0.3%

- Check35 days agoChange DetectedThe Study Record History now lists revision v3.6.6, with v3.6.5 removed from the history. This indicates an update to the page's revision history and versioning metadata.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now shows a new revision version v3.6.5, replacing the previous v3.6.4. This reflects a system/UI update to the page rather than a change to the study content.SummaryDifference0.1%

- Check71 days agoChange DetectedNew revision entry added: Revision: v3.6.4, and Revision: v3.6.3 removed from the record history. This update changes only the version history on the page and does not affect trial data or content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history shows the site revision updated from v3.6.2 to v3.6.3, indicating a minor interface update.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, and the previous revision (v3.6.0) was removed. This update reflects a maintenance change to the page's version history rather than a modification to the study content.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.